Key facts
- Open Bionics’s last known valuation is $28.3M (May 2025).
- It has raised $22.0M; the latest was Later Stage VC ($3.8M) in May 2025.
- Notable investors include Innovate UK, Disney Accelerator, Ananda Impact Ventures, Bioscience Managers, Bristol Robotics Laboratory — 20 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 20 names
- ·Watchlist + deal alerts for Open Bionics
- ·The full record, as it builds
Funding rounds
No funding rounds for Open Bionics are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Open Bionics
Developer of three-dimensional printed robotic limbs designed to help under-elbow amputees regain mobility. The company's assistive devices offer multiple grip functionality, custom-fitted designs, and lightweight materials, enabling individuals with limb differences to perform daily tasks with greater ease and access to an affordable, personalized solution.
- Sector
- Healthcare
- HQ
- Bristol, United Kingdom
- Founded
- 2014
- Employees
- 49
- Website
- openbionics.com/
- Ownership
- Privately Held (backing)
Open Bionics doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Open Bionics shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Open Bionics in its N-PORT filings yet. We sweep new filings monthly.